Published in World J Surg on March 01, 2006
Surgical treatment of hepatocellular carcinoma. Surg Today (2009) 0.97
3D virtual reality and selective vascular control for laparoscopic left hepatic lobectomy. Surg Endosc (2008) 0.92
Detection of intrahepatic veno-venous shunts by three-dimensional venography using multidetector-row computed tomography during angiography. Surg Today (2013) 0.92
Resection of metastatic liver cancer in a patient with a left-sided gallbladder and intrahepatic portal vein and bile duct anomalies: A case report. Int J Surg Case Rep (2012) 0.88
CLIP method (preoperative CT image-assessed ligation of inferior pancreaticoduodenal artery) reduces intraoperative bleeding during pancreaticoduodenectomy. World J Surg (2008) 0.86
Usefulness of artificial vascular graft for venous reconstruction in liver surgery. World J Surg Oncol (2014) 0.79
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
Preoperative detection of intrahepatic venovenous shunt treated by microwave precoagulation during right hepatectomy. World J Gastrointest Pharmacol Ther (2015) 0.75
Renal infarct volume and renal function decline in acute and chronic phases. Clin Exp Nephrol (2017) 0.75
Management of centrally located hepatocellular carcinoma: Update 2016. World J Hepatol (2017) 0.75
Three-dimensional computed tomography simulation for laparoscopic lymph node dissection in the treatment of proximal gastric cancer. Transl Gastroenterol Hepatol (2017) 0.75
Anatomy of the biliary ducts within the human liver; analysis of the prevailing pattern of branchings and the major variations of the biliary ducts. AMA Arch Surg (1953) 3.83
[Liver lobes and segments: notes on the anatomical architecture and surgery of the liver ]. Presse Med (1954) 2.18
Operative morbidity of living liver donors in Japan. Lancet (2003) 2.13
Spiral volumetric CT with single-breath-hold technique, continuous transport, and continuous scanner rotation. Radiology (1990) 2.11
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01
Four multidetector-row helical CT: image quality and volume coverage speed. Radiology (2000) 1.92
Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg (1999) 1.42
Preoperative simulation of vascular anatomy by three-dimensional computed tomography imaging in laparoscopic gastric cancer surgery. J Am Coll Surg (2003) 1.31
Different approaches to caudate lobectomy with "curettage and aspiration" technique using a special instrument PMOD: a report of 76 cases. World J Gastroenterol (2003) 1.27
The caudate lobe of the liver: implications of embryology and anatomy for surgery. Surg Oncol Clin N Am (2002) 1.16
Surgical outcomes of isolated caudate lobe resection: a single series of 19 patients. Surgery (2002) 1.15
Intrahepatic portal vein branches studied by percutaneous transhepatic portography. Radiology (1985) 1.02
Three-dimensional imaging. Radiology (1991) 1.00
High dorsal resection of the liver. J Am Coll Surg (1994) 0.98
Right trisegmentectomy with a synthetic vena cava graft. Arch Surg (1988) 0.93
Segmental liver resections, present and future-caudate lobe resection for liver tumors. Hepatogastroenterology (1998) 0.93
Peripheral anatomic evaluation using 3D CT hepatic venography in donors: significance of peripheral venous visualization in living-donor liver transplantation. AJR Am J Roentgenol (2004) 0.83
Repeated liver resection for recurrent metastases from colorectal cancer. Hepatogastroenterology (2003) 0.76
Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 3.09
Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg (2004) 2.57
Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. Int J Radiat Oncol Biol Phys (2003) 2.00
Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Clin Cancer Res (2006) 1.90
Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Hepatology (2013) 1.76
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer (2005) 1.73
Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol Cell Biol (2002) 1.72
Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax (2007) 1.61
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum (1986) 1.59
Transient portacaval shunt for a small-for-size graft in living donor liver transplantation. Liver Transpl (2007) 1.57
Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation. Transplantation (2002) 1.57
Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Ann N Y Acad Sci (2003) 1.56
Splenic volume measurements on computed tomography utilizing automatically contouring software and its relationship with age, gender, and anthropometric parameters. Eur J Radiol (2009) 1.56
Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.49
Risk factors for portal vein complications in pediatric living donor liver transplantation. Clin Transplant (2010) 1.39
Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol (2004) 1.37
Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J Hepatol (2005) 1.31
Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization. Ann Surg Oncol (2009) 1.30
She4p/Dim1p interacts with the motor domain of unconventional myosins in the budding yeast, Saccharomyces cerevisiae. Mol Biol Cell (2003) 1.29
Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg (2010) 1.28
The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation. Hepatology (2009) 1.26
A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity. Biochem Biophys Res Commun (2003) 1.19
Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today (2002) 1.19
Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway. Clin Cancer Res (2005) 1.19
Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2005) 1.18
Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration (2003) 1.17
The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther (2008) 1.15
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. J Gastroenterol (2009) 1.13
Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.11
Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology (2008) 1.10
Postnatal management for prenatally diagnosed choledochal cysts. J Pediatr Surg (2004) 1.09
CT-guided transbronchial biopsy using an ultrathin bronchoscope with virtual bronchoscopic navigation. Chest (2004) 1.08
UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination. Oncogene (2005) 1.08
Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. Cancer Res (2002) 1.07
Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. Pancreas (2011) 1.06
Transbronchial biopsy using endobronchial ultrasonography with a guide sheath and virtual bronchoscopic navigation. Chest (2005) 1.06
Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses. Clin Cancer Res (2004) 1.05
Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology (2004) 1.04
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination. Cancer Biol Ther (2010) 1.04
Alveolar echinococcosis: MR findings in the liver. Radiology (2003) 1.04
BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics. Mol Cell Proteomics (2007) 1.03
N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma. Mol Cancer (2007) 1.03
A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys. Transplantation (2007) 1.03
Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients. Oncol Rep (2010) 1.03
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl (2011) 1.02
Three-dimensional computed tomography scan analysis of hepatic vasculatures in the donor liver for living donor liver transplantation. Liver Transpl (2010) 1.01
Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function. J Biol Chem (2002) 1.01
A long-term survival case of adult undifferentiated embryonal sarcoma of liver. World J Surg Oncol (2012) 1.00
Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Oncol (2013) 0.99
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Oncol Rep (2010) 0.99
Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide. Cancer Sci (2003) 0.98
C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma. J Gastroenterol (2013) 0.97
Virtual bronchoscopic navigation system shortens the examination time--feasibility study of virtual bronchoscopic navigation system. Lung Cancer (2007) 0.97
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice. J Crohns Colitis (2011) 0.97
Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer. Int J Oncol (2012) 0.96
Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB. Oncogene (2003) 0.95
Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94
Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol (2011) 0.94
TRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancers. Carcinogenesis (2011) 0.94
AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg (2006) 0.93
Pulmonary resection for metastases from hepatocellular carcinoma: factors influencing prognosis. J Thorac Cardiovasc Surg (2006) 0.92